Abstract:To investigate changes in human leucocyte antigen (HLA)-DR expression on peripheral monocytes, determine the value of predicting the development of stroke-associated infection (SAI), and determine the correlation with other conditions in critically-ill patients in the neurological intensive care unit (NICU) who suffered an acute stroke.All patients were enrolled consecutively and admitted to NICU within 24 h after the onset of symptoms. Patients were followed in order to identify whether infection developed and determine survival status within 2 weeks after the stroke. Patients were divided into stroke or control group by study design, infection or non-infection group by whether or not they had an infection, survival or death group by prognosis and cerebral infarction or cerebral haemorrhage group by stroke type. Patients in which acute stroke was excluded by head CT or MRI were admitted to general ward and were used as a control group. Blood samples were collected serially on days 1, 2, 4, 6 and 14 after stroke, then monocyte human leucocyte antigen-DR (HLA-DR) expression was determined by flow cytometry. The National Institute of Health Stroke Scale (NIHSS), Acute Physiology and Chronic Health Evaluation II (APACHEII) and Glasgow Coma Scale (GCS) scores were recorded over the course of observation.Fifty-three subjects and 39 controls were enrolled in the study. On days 1, 2, 4, 6 and 14, there was a significant difference in monocyte HLA-DR expression between stroke group and control group (all P < 0.001), but no difference was found between ischaemic stroke group and haemorrhagic stroke group (all P > 0.05). The infection group compared with non-infection group did not exhibit a significant difference in HLA-DR expression on days 1 and 2 (all P > 0.05), but significant differences emerged on days 4, 6 and 14 (all P < 0.01). On days 1 and 2 the HLA-DR expression in the survival group compared with death group, was not significantly different (all P > 0.05), but differences became significant on days 4 and 6 (P < 0.01). On day 1, HLA-DR expression < 62.80% had the predictive value to SAI (sensitivity 83.3%, specificity 55.2%, AUC = 0.661, P = 0.031) and on day 2, HLA-DR expression < 57.83% had the predictive value to SAI (sensitivity 95.8%, specificity 79.3%, AUC = 0.907, P = 0.000) in acute stroke patients. A statistically significant inverse correlation was found between NIHSS and HLA-DR on days 2 and 4 during the observation period (all P < 0.01), but there was no statistically significant negative correlation on days 1, 6 or 14 (all P > 0.05). HLA-DR expression did not correlate with APACHEII (all P > 0.05) or GCS (all P > 0.05) during the measurement period.Human leucocyte antigen-DR (HLA-DR) expression decreases and sustains a dynamic change and it also relates to the severity of patient's condition in the critically-ill patients with stroke. Progressively persistent low monocyte HLA-DR expression is associated with a poor prognosis. The decline in HLA-DR expression contributes to infection in critically-acute stroke patients. Monitoring of monocyte HLA-DR expression may be useful for identifying patients suffering from acute stroke who are at high risk for infection.

Decreased Monocytic HLA-DR in Patients with Sepsis: Prediction of Diagnosis, Severity and Prognosis

HLA-DR Expression on Monocytes and Sepsis Index Are Useful in Predicting Sepsis

Expression Of Monocyte Hla-Dr And Blood Lactic Acid Level In Patients With Sepsis And Correlation With Prognosis

Changes of Monocyte Human Leukocyte Antigen-Dr Expression As a Reliable Predictor of Mortality in Severe Sepsis.

An integrative model with HLA‐DR, CD64, and PD‐1 for the diagnostic and prognostic evaluation of sepsis

Monocytic Human Leukocyte Antigen-DR Expression Levels to Predict Outcome in Children With Severe Sepsis

Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study

Dynamic changes in human HLA-DRA gene expression and Th cell subsets in sepsis: Indications of immunosuppression and associated outcomes

Monocyte HLA-DR level on admission predicting in-hospital mortality rate in exertional heatstroke: A 12-year retrospective study

Inverse Correlation Between Plasma Sphingosine-1-Phosphate and Ceramide Concentrations in Septic Patients and Their Utility in Predicting Mortality.

Monocytic HLA-DR expression and clinical outcomes in adult ICU patients with sepsis – a systematic review and meta-analysis

Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma

Study on the Relationship Between the Human Leucocyte Antigen-Dr Expression on CD14~+ Monocytes and Sepsis

Efficiency of Monocyte/High-Density Lipoprotein Cholesterol Ratio Combined With Neutrophil/Lymphocyte Ratio in Predicting 28-Day Mortality in Patients With Sepsis

A Decrease of Human Leucocyte Antigen‐dr Expression on Monocytes in Peripheral Blood Predicts Stroke‐associated Infection in Critically‐ill Patients with Acute Stroke

Immunoparalysis: Clinical and immunological associations in SIRS and severe sepsis patients

Peripheral PD-1+NK cells could predict the 28-day mortality in sepsis patients

Expression of Peripheral Blood DCs CD86, CD80, and Th1/Th2 in Sepsis Patients and Their Value on Survival Prediction

Ratio of neutrophilic CD64 and monocytic HLA-DR: A novel parameter in diagnosis and prognostication of neonatal sepsis

Combination of NK and Other Immune Markers at Early Phase Stratify the Risk of Sepsis Patients: A Retrospective Study

[Value of peripheral blood monocyte subsets and CD64 expression in the diagnosis and prognosis of sepsis]